Preventing Pancreatitis After Shock Wave Therapy for Pancreatic Stones
Treatments studied
Part of Digestive system clinical trials.
This study tests whether a combination of an NSAID (indomethacin) given rectally plus extra fluids through an IV can prevent pancreatitis after shock wave therapy for pancreatic stones. It may help reduce inflammation and protect your pancreas during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic pancreatitis that causes pain and you are scheduled for shock wave therapy (ESWL) to break up stones in your pancreas.
- You are between 18 and 85 years old.
- You have not taken NSAID pain relievers (like ibuprofen, naproxen, or indomethacin) in the last week.
- You do not have serious heart problems (like heart failure, low blood pressure, or abnormal heart function) or lung problems that require oxygen.
- You have good kidney function (no kidney disease or recent dialysis) and no active stomach bleeding, allergies, or blood clotting issues.
- You are not pregnant, breastfeeding, or have had surgery removing your rectum.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a drug called pinaverium bromide can help prevent pancreatitis and reduce pain after a procedure that uses shock waves to break up large gallstones in the pancreas. It may be an option for people with chronic pancreatitis and stones that are at least 5 mm wide.
This trial compares two ways to break and remove pancreatic duct stones in people with long-term pancreas pain caused by calcified stones. It looks to see which approach helps reduce pain more effectively and safely.
This trial tests whether parecoxib or indomethacin works better at preventing pancreatitis, a common complication after a procedure called ERCP. Participants will receive one of the two medicines before the procedure, and the study will track which one is safer and more effective.
This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.
This study tests whether combining a rectal anti-inflammatory medication (indomethacin) with cold water cooling of the pancreas opening during an endoscopic procedure can better prevent pancreatitis—a painful inflammation of the pancreas—compared to medication alone.
This study tests whether placing a small tube (prosthesis) in the pancreas before removing gallbladder and bile duct stones during ERCP can prevent pancreatitis. It is for people with small gallbladder stones and bile duct stones who are at higher risk for pancreatitis after the procedure.
Hear when a new Pancreatitis, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.